TAK-999-3003
The main aim of this study is to learn if fazirsiran is safe during long-term use in people with liver disease caused by the abnormal Z-alpha-1 antitrypsin (Z-AAT) protein. People who are currently taking part in or have completed previous…
- Investigator
- Ginger Clark
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Takeda TAK-999-3001
The main aim of this study is to learn if fazirsiran reduces liver scarring (fibrosis) compared to placebo. Other aims are to learn if fazirsiran slows down the disease worsening in the liver, to get information on how fazirsiran affects the body…
- Investigator
- Ginger Clark
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
NN9931-4553 ESSENCE
Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries.
Participants will either get semaglutide or a dummy medicine * which…
- Investigator
- Ginger Clark
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All